Product
SP-8356
1 clinical trial
2 indications
Indication
AtherosclerosisIndication
strokeClinical trial
A Phase I Single-Centre, Randomised, Double-Blind, Placebo-Controlled Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8356Status: Terminated, Estimated PCD: 2021-10-28